Barbara White, Chief Medical Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 2,570 shares at $3.52 ($9K) on 2016-06-01, disclosed to the SEC on 2016-06-02.
Open-market purchase of $9k CRBP by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CRBP | BUY | 2019-08-13 | $10K | — | Filing → |
| CRBP | BUY | 2019-05-20 | $10K | — | Filing → |
| CRBP | BUY | 2019-03-14 | $30K | — | Filing → |